<PAGE> 1

                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549

                                FORM 10-QSB

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934

                For the Quarter Ended September 30, 2002


                      Commission File Number 0-24721



                         LEXON TECHNOLOGIES, INC.
           -----------------------------------------------------
          (Exact Name of Registrant, as Specified in its Charter)


              Delaware                                  87-0502701
-------------------------------           ----------------------------------
(State or other Jurisdiction of          (IRS Employer Identification Number)
 Incorporation or Organization)



             2691 Richter Avenue, #124, Irvine, California 92623
             ---------------------------------------------------
                 (Address of Principle Executive Offices)


                             (949)757-0888
           --------------------------------------------------
          (Registrant's Telephone Number, Including Area Code)


Indicate, by check mark, whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

(1) Yes X   No       (2) Yes X   No
       ---    ---           ---    ---

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

Common Stock, $.001 par value                        19,428,683
-----------------------------                  ----------------------------
     Title of Class                            Number of Shares Outstanding
                                               as of September 30, 2002

<PAGE>
<PAGE> 2


                        PART I FINANCIAL INFORMATION

                        ITEM 1.  FINANCIAL STATEMENTS

                  LEXON TECHNOLOGIES, INC. AND SUBSIDIARY
                             FINANCIAL STATEMENTS
                                 (UNAUDITED)

     The accompanying financial statements have been prepared by the
Company, without audit, in accordance with the instructions to Form 10-QSB
pursuant to the rules and regulations of the Securities and Exchange
Commission and, therefore may not include all information and footnotes
necessary for a complete presentation of the financial position, results of
operations, cash flows, and stockholders' equity in conformity with generally
accepted accounting principles.  In the opinion of management, all adjustments
(which include only normal recurring accruals) necessary to present fairly the
financial position and results of operations for the periods presented have
been made.  These financial statements should be read in conjunction with the
accompanying notes, and with the historical financial information of the
Company.
<PAGE>
<PAGE> 3

LEXON TECHNOLOGIES, INC. AND SUBSIDIARY
(A Development Stage Company)
Consolidated Balance Sheets

ASSETS
                                                  September 30,  December 31,
                                                       2002          2001
                                                   -----------   -----------
                                                   (Unaudited)
CURRENT ASSETS
 Cash and cash equivalents                        $     51,390  $     36,134
 Cash held in trust                                          -       150,000
 Loans receivable - related parties                     52,769        30,769
 Advances to officers                                    7,500             -
                                                   -----------   -----------
   Total Current Assets                                111,659       216,903
                                                   -----------   -----------
FIXED ASSETS, NET                                        8,937         7,075
                                                   -----------   -----------
OTHER ASSETS                                             8,000             -
                                                   -----------   -----------
TOTAL ASSETS                                      $    128,596  $    223,978
                                                   ===========   ===========


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES
 Accounts payable                                 $    276,461  $      2,587
 Accounts payable - related party                       12,450         4,851
 Accrued wages                                         272,514             -
 Other accrued expenses                                  7,266             -
                                                   -----------   -----------
   Total Current Liabilities                           568,691         7,438
                                                   -----------   -----------
STOCKHOLDERS' EQUITY (DEFICIT)
 Common stock, par value $0.001 per share;
  authorized 100,000,000 shares; 19,428,683
  and 17,500,000 shares issued and
  outstanding, respectively                             19,429        17,500
 Additional paid-in capital                            362,328       941,220
 Subscription receivable                                     -      (220,000)
 Deficit accumulated during the development stage     (821,852)     (522,180)
                                                   -----------   -----------
   Total Stockholders' Equity (Deficit)               (440,095)      216,540
                                                   -----------   -----------
TOTAL LIABILITIES AND STOCKHOLDERS'
 EQUITY (DEFICIT)                                 $    128,596  $    223,978
                                                   ===========   ===========





The accompanying notes are an integral part of these consolidated financial
statements.

<PAGE>
<PAGE> 4

LEXON TECHNOLOGIES, INC. AND SUBSIDIARY
(A Development Stage Company)
Consolidated Statements of Operations
(Unaudited)

<TABLE>
<CAPTION>

                                                                                                 From Inception
                                                    For the                     For the         on July 18, 2001
                                               Three Months Ended           Nine Months Ended        Through
                                                  September 30,               September 30,        September 30,
                                               2002          2001          2002          2001          2002
                                            -----------   -----------   -----------   -----------   -----------
<S>                                      <C>           <C>           <C>           <C>           <C>
REVENUES                                   $          -  $          -  $          -  $          -  $          -
                                            -----------   -----------   -----------   -----------   -----------
EXPENSES
 Research and development                             -             -             -             -       405,000
 Selling, general and administrative            136,531        68,395       300,712        68,395       417,669
 Depreciation and amortization                      862             -         2,097             -         2,320
                                            -----------   -----------   -----------   -----------   -----------
   Total Expenses                               137,393        68,395       302,809        68,395       824,989
                                            -----------   -----------   -----------   -----------   -----------
LOSS FROM OPERATIONS                           (137,393)      (68,395)     (302,809)      (68,395)     (824,989)
                                            -----------   -----------   -----------   -----------   -----------
OTHER INCOME (EXPENSE)
 Interest income                                      -             -         3,137             -         3,137
                                            -----------   -----------   -----------   -----------   -----------
   Total Other Income (Expense)                       -             -         3,137             -         3,137
                                            -----------   -----------   -----------   -----------   -----------
NET LOSS                                   $   (137,393) $    (68,395) $   (299,672) $    (68,395) $   (821,852)
                                            ===========   ===========   ===========   ===========   ===========
BASIC LOSS PER SHARE                       $      (0.01) $      (0.00) $      (0.02) $      (0.00)
                                            ===========   ===========   ===========   ===========

WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING                    19,157,813    15,568,649    18,264,008    15,568,649
                                            ===========   ===========   ===========   ===========
</TABLE>





The accompanying notes are an integral part of these consolidated financial
statements.

<PAGE>
<PAGE> 5

LEXON TECHNOLOGIES, INC. AND SUBSIDIARY
(A Development Stage Company)
Consolidated Statements of Cash Flows
(Unaudited)
<TABLE>
<CAPTION>
                                                                                                 From Inception
                                                                                                on July 18, 2001
                                                                        For the Nine Months Ended    Through
                                                                              September 30,        September 30,
                                                                           2002          2001          2002
                                                                        -----------   -----------   -----------
<S>                                                                  <C>           <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
 Net loss                                                              $   (299,672) $    (68,395) $   (821,852)
 Adjustments to reconcile net loss to net cash
 (used) in operating activities:
  Depreciation and amortization                                               2,097             -         2,320
  Stock for services                                                              -        13,720        13,720
  Stock for technology                                                            -             -       375,000
 Changes in assets and liabilities:
  Increase in other assets                                                   (8,000)            -        (8,000)
  Increase (decrease) in accounts payable
   and accrued expenses                                                    (120,118)        3,000      (112,680)
                                                                        -----------   -----------   -----------
   Net Cash (Used) in Operating Activities                                 (425,693)      (51,675)     (551,492)
                                                                        -----------   -----------   -----------
CASH FLOWS FROM INVESTING ACTIVITIES:
 Cash paid for property and equipment                                        (3,959)       (1,834)      (11,257)
 Cash paid for related party notes receivables                              (27,000)      (25,385)      (67,769)
 Cash received from related party notes receivables                           5,000             -        15,000
 Advances to officers                                                        (7,500)       (3,187)       (7,500)
 Cash placed into escrow                                                          -             -      (150,000)
 Cash received from escrow                                                  150,000             -       150,000
 Cash paid for note receivable                                             (200,000)            -      (200,000)
 Note receivable converted in acquistion                                    200,000             -       200,000
 Cash received in acquisition                                                34,408             -        34,408
                                                                        -----------   -----------   -----------
   Net Cash Used in Investing Activities                                    150,949       (30,406)      (37,118)
                                                                        -----------   -----------   -----------
CASH FLOWS FROM FINANCING ACTIVITIES:
 Receipt of subscription receivable                                         220,000             -       220,000
 Cash received from issuance of common stock                                 70,000       150,000       420,000
                                                                        -----------   -----------   -----------
   Net Cash Provided by Financing Activities                                290,000       150,000       640,000
                                                                        -----------   -----------   -----------
NET INCREASE IN CASH AND CASH EQUIVALENTS                                    15,256        67,919        51,390

CASH AND CASH EQUIVALENTS AT BEG OF PERIOD                                   36,134             -             -
                                                                        -----------   -----------   -----------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                             $     51,390  $     67,919  $     51,390
                                                                        ===========   ===========   ===========
SUPPLEMENTAL CASH FLOW INFORMATION

Cash Payments For:
 Interest                                                              $          -  $          -  $          -
 Income taxes                                                          $          -  $          -  $          -

Non-Cash Investing and Financing Activities
 Stock issued for technology                                           $          -  $          -  $    375,000
 Stock issued for services                                             $          -  $     13,720  $     13,720

</TABLE>


The accompanying notes are an integral part of these consolidated financial
statements.

<PAGE>
<PAGE> 6

LEXON TECHNOLOGIES, INC. AND SUBSIDIARY
(A Development Stage Company)
Notes to the Consolidated Financial Statements
September 30, 2002 and December 31, 2001

NOTE 1 -BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared
by the Company pursuant to the rules and regulations of the Securities and
Exchange Commission.  Certain information and footnote disclosures normally
included in financial statements prepared in accordance with generally
accepted accounting principles have been condensed or omitted in accordance
with such rules and regulations.  The information furnished in the interim
condensed financial statements include normal recurring adjustments and
reflects all adjustments, which, in the opinion of management, are necessary
for a fair presentation of such financial statements.  Although management
believes the disclosures and information presented are adequate to make the
information not misleading, it is suggested that these interim condensed
financial statements be read in conjunction with the Company's audited
financial statements and notes thereto included in its December 31, 2001
Annual Report on Form 10-KSB.  Operating results for the nine months ended
September 30, 2002 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2002.

NOTE 2 -GOING CONCERN

The Company's consolidated financial statements are prepared using generally
accepted accounting principles applicable to a going concern which
contemplates the realization of assets and liquidation of liabilities in the
normal course of business.  The Company has historically incurred significant
losses which have resulted in an accumulated deficit of $821,852 at September
30, 2002, a working capital deficit of approximately $440,000 and limited
internal financial resources.  These factors combined, raise substantial doubt
about the Company's ability to continue as a going concern.  The accompanying
consolidated financial statements do not include any adjustments relating to
the recoverability and classification of asset carrying amounts or the amount
and classification of liabilities that might result from the outcome of this
uncertainty.

NOTE 3 -MATERIAL EVENTS

On September 27, 2002, the Company issued 280,000 shares of outstanding common
stock to a private investor at $0.25 per share for total proceeds of $70,000.


<PAGE>
<PAGE> 7

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

Cautionary Statement Regarding Forward-looking Statements
---------------------------------------------------------
This report may contain "forward-looking" statements.  Examples of forward-
looking statements include, but are not limited to: (a) projections of
revenues, capital expenditures, growth, prospects, dividends, capital
structure and other financial matters; (b) statements of plans and objectives
of our management or Board of Directors; (c) statements of future economic
performance; (d) statements of assumptions underlying other statements and
statements about us and our business relating to the future; and (e) any
statements using the words "anticipate," "expect," "may," "project," "intend"
or similar expressions.

General
-------
On April 14, 2002, we entered into a merger agreement (effective May 27, 2002)
with Phacon Corporation ("Phacon") to acquire 100% of the outstanding common
stock of Phacon by issuing to the Phacon shareholders 17,500,000 shares of our
common stock after effecting a 1-for-10 reverse split of our previously issued
and outstanding shares.  This merger transaction has been accounted for in the
consolidated financial statements included with this report as a reverse
acquisition.  As a result of this transaction, the shareholders of Phacon
acquired or exercised control over a majority of our shares.  Accordingly, the
transaction has been treated for accounting purposes as a recapitalization of
Phacon; therefore, the consolidated financial statements and the discussion
and analysis below represent a continuation of Phacon, not Lexon, the legal
survivor.  Phacon is treated as the survivor for accounting purposes and Lexon
is the survivor for legal purposes.  Because Phacon was incorporated in July
2001, the prior year periods may not be directly applicable for comparative
purposes.  Our business going forward is the business of Phacon.

Business
--------
Phacon was formed in July of 2001 to commercialize a proprietary device and
proprietary software package that reduces the amount of electricity required
to power various indoor lighting devices in commercial buildings, factories,
and office structures, as well as outdoor street and parking lot lighting.
Since Phacon's inception, it has been involved in the development of its
technology.  Our business activities to date have included raising capital,
developing prototype devices and installing test systems in Canada and Korea,
and beginning to establish a marketing and sales distribution network.  We
have also been seeking joint venture partners, business acquisitions and
business alliances to attempt to create some synergy with our planned
operations, although we have not reached any definitive agreements to date.

Results of Operations
---------------------
Three and Nine Months Ended September 30, 2002 compared to September 30, 2001
-----------------------------------------------------------------------------
We had no revenues for the nine months ended September 30, 2002 and have had
no revenues from inception (July 18, 2001) to date.  We expect that our
initial revenues will be generated by the sale of energy saving lighting and
related products.  Additional revenues may be derived from the licensing of
our proprietary technology.

<PAGE>
<PAGE> 8

Operating expenses for the three and nine months ended September 30, 2002 were
$137,393 and $302,809, respectively, consisting primarily of $115,810 and
$164,181 for general and administrative expenses.  Operating expenses for the
prior year periods were $68,395 and $68,395, respectively.  The increase in
operating expenses from 2001 reflects the fact that our business prior to the
merger with Phacon was essentially dormant.  Since the merger, management has
been actively working to develop our business.  Operating expenses since
inception (July 18, 2001) total $824,989, consisting primarily of $405,000 for
research and development, and $417,669 for general and administrative
expenses.  Our net losses per share for the three and nine months ended
September 30, 2002 were $0.01 and $0.02, respectively, based on a weighted
average of 19,157,813 and 18,264,008 shares outstanding.

Provided adequate funding is found, we anticipate that operating expenses will
increase substantially as research and production staff is hired and sales and
marketing operations commence.

Liquidity and Capital Resources
-------------------------------
Our primary source of liquidity has been cash proceeds from the sale of our
common stock.  We anticipate that we will need to raise significant additional
capital to complete development of our technology and bring our existing
product to market.  At this date we have no agreements or commitments for
funding.

At September 30, 2002, we had a working capital deficit of $457,032.  We had
cash and cash equivalents of $51,390.  We also have related party loans
receivable of $52,769 and advances to officers of $7,500.  We expect these
loans and advances to be repaid within the next twelve months.

Liabilities at September 30, 2002 total $568,691, consisting of primarily of
accounts payable of $276,461, and accrued wages of $272,514.  In August 2002,
we entered into an oral agreement to pay J. Jehy Lah, the chairman of our
board of directors, a salary of $135,000 per year.  We also entered into an
oral agreement to pay Ben Hwang, our Secretary, a salary of $85,000 per year.
These salaries and the salary of Kenneth Eaken, our C.E.O. and President, are
all being accrued until such time as funds are operating revenues are
sufficient to pay the accrued amounts.

For the nine months ended September 30, 2002, cash flows used by operating
activities totaled $425,693.  Our operating activities since inception have
been funded by the sale of our common stock.

Cash provided by investing activities totaled $150,949, consisting of cash
received from related party notes receivable, cash received from escrow, and
cash received in the acquisition, offset by cash paid for property and
equipment, cash paid for related party notes receivable and advances to
officers.

Cash provided by financing activities consisted of $220,000 received for a
subscription receivable for the sale of common stock and $70,000 received from
the sale of common stock to a shareholder.

<PAGE>
<PAGE> 9

Because we have had no operations, have an operating loss and are dependent on
financing to continue operations, our financial statements contain a going
concern qualification.  We intend to seek debt financing from traditional
lending sources, loans from or private sales of our securities to our existing
officers, directors, and shareholders, or such other debt or equity offerings
that may be available to us.  There is no assurance that we will be able to
obtain funding when and if needed, or that such funding, if available, can be
obtained on terms reasonable or acceptable to us.

ITEM 3. CONTROLS AND PROCEDURES
(a) Evaluation of disclosure controls and procedures. We believe our
disclosure controls and procedures (as defined in Sections 13a-14(c) and 15d-
14(c) of the Securities Exchange Act of 1934, as amended) are adequate, based
on our evaluation of such disclosure controls and procedures on September 25,
2002.
(b) Changes in internal controls. There were no significant changes in our
internal controls or in other factors that could significantly affect these
controls subsequent to the date of their evaluation.

PART II - OTHER INFORMATION
ITEM 1.  LEGAL PROCEEDINGS
We are not aware of any material pending or threatened litigation.

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS
In September 2002, we issued 280,000 shares of restricted common stock to a
shareholder and director, Kyu Hong Hwang, at $0.25 per share for proceeds of
$70,000 cash.  The shares were issued at a discount to market due to the
restricted nature of the stock.  The shares issued in the foregoing
transactions were issued in reliance on the exemption from registration and
prospectus delivery requirements of the Act set forth in Section 3(b) and/or
Section 4(2) of the Securities Act and the regulations promulgated thereunder.

ITEM 3.  DEFAULT BY THE COMPANY ON ITS SENIOR SECURITIES
None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS
None.

ITEM 5.  OTHER INFORMATION
None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
    --------
Exhibit 99 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

(b) Reports on Form 8-K
    -------------------
None.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of  1934, we have
duly caused this report to be signed on our behalf by the undersigned,
thereunto duly authorized.

LEXON TECHNOLOGIES, INC.

Date: November 13, 2002

/S/Kenneth J. Eaken, President, C.E.O. and C.F.O.

<PAGE>
<PAGE> 10

                              CERTIFICATIONS

I, Kenneth J. Eaken, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Lexon Technologies,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this quarterly report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this quarterly report is being
prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness
of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function);

a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control;
and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether of not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date: November 13, 2002                           /S/Kenneth J. Eaken
                                                 Principal Executive Officer
                                                 Principal Financial Officer